Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 162 publications
Somatic Mutation Profiles in Colorectal Cancers Differ by Population.
Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2026
Race and Socioeconomic Status Impact Survival from Early and Late-Onset Colorectal Cancer.
Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2026
Survival benefits of varying physical activity levels in a heterogeneous colorectal cancer cohort: The Disparities and Cancer Epidemiology (DANCE) study.
Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2026
Performance of family history-based colorectal cancer screening criteria by race and age at diagnosis in the Disparities and Cancer Epidemiology (DANCE) study.
Journal: medRxiv : the preprint server for health sciences
Published: June 29, 2026
Fatty acids in the tumor microenvironment reprogram neutrophils to induce immunosuppression via adenosine.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Factors Associated with Gastric Signet Ring Cell Carcinoma in CDH1 Pathogenic Variant Carriers: Report from the GASTRIC Consortium.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 25, 2026
Colorectal Cancer Screening in Hereditary and Familial High-Risk Populations: Best Practices and Future Directions.
Journal: International journal of cancer
Published: March 15, 2026
Optimizing Reporting and Outreach for Surveillance and Risk-Reducing Surgeries for Cancer Genetic Predisposition: Findings of a Workshop Organized by the International Cascade Consortium.
Journal: Public health genomics
Published: March 07, 2026
Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing Registry.
Journal: European urology open science
Published: February 11, 2026
Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet).
Journal: Frontiers in immunology
Published: February 11, 2026
Last Updated: 09/26/2026